SAGILITY LIMITED has informed the Exchange about Transcript of Investor and Analyst Day held on March 25, 2026
SAGILITY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sagility hosted its annual Investor & Analyst Day outlining its healthcare operations transformation strategy. The company serves US healthcare payers (87-88% revenue) and providers, working with 7 of top 10 US payers with average 18-year client tenure. Management explained how current US healthcare margin pressures (MLRs rising to 90%+) actually benefit Sagility as clients seek cost reduction partners. Top 5 clients grew 9.9% and other clients grew 28% in the last 12 months. The company is investing in Agentic AI through 'SmarTec agents' and 'Synchrony' end-to-end solutions, moving toward outcome-based managed services contracts. They are also targeting the fragmented mid-market payer segment with bundled technology solutions. EBITDA margins have been consistently in the 24-25% range.
The company appears well-positioned to capture additional market share as US healthcare payers face margin compression and seek cost-efficient outsourcing partners. The shift to outcome-based contracts could provide more predictable revenue but may alter margin profile.